KRAS and neoplasm: The presence of KRAS mutation microheterogeneity in many tumours which are KRAS wild-type by standard sequencing technologies together with the absence of KRAS mutational macroheterogeneity further indicated that these new subclones rarely undergo significant clonal expansion.